Dual ALK/EGFR Inhibitor AP26113

An orally available inhibitor of receptor tyrosine kinases anaplastic lymphoma kinase (ALK) and the epidermal growth factor receptor (EGFR) with potential antineoplastic activity. Dual ALK/EGFR inhibitor AP26113 binds to and inhibits ALK kinase and ALK fusion proteins as well as EGFR and mutant forms. This leads to the inhibition of ALK kinase and EGFR kinase, disrupts their signaling pathways and eventually inhibits tumor cell growth in susceptible tumor cells. In addition, AP26113 appears to overcome mutation-based resistance. ALK belongs to the insulin receptor superfamily and plays an important role in nervous system development; ALK dysregulation and gene rearrangements are associated with a series of tumors. EGFR is overexpressed in a variety of cancer cell types. (NCI Thesaurus)

YOU MAY ALSO LIKE

DU 145

A cell line made from human prostate cancer cells that is used in the laboratory to study the way prostate cancer cells…

DTX2 wt Allele

Human DTX2 wild-type allele is located in the vicinity of 7q11.23 and is approximately 44 kb in length. This allele, which encodes…

DTX2 Gene

This gene plays a role in regulation of cell-cell communication.

DTX1 wt Allele

Human DTX1 wild-type allele is located in the vicinity of 12q24 and is approximately 40 kb in length. This allele, which encodes…

DTX1 Gene

This gene is involved in signal transduction and regulation of transcription. It also plays a role in development.

DTL wt Allele

Human DTL wild-type allele is located in the vicinity of 1q32 and is approximately 72 kb in length. This allele, which encodes…